artoo
artoo makes any-to-any clinical dataset conversion lossless by construction.
A side-by-side editorial comparison of humind and PowerTOST — release velocity, themes, recent moves, and the top alternatives to consider.
The MSNI humanitarian needs framework as code, rewritten and re-broken every year
humind turns household survey data into Multi-Sector Needs Index severity scores across WASH, Protection, SNFI, Food Security, Education and Health. Its version line tracks the annual MSNI framework revision — 2024.x, 2025.x, 2026.x — with narrow correctness patches between rollouts. v2026.2.0 is the current rollout and the most structural one in the visible history: water-quantity scoring moved out into a new mandatory prerequisite, food-security severity now comes from a different matrix, and the impactR4PHU runtime dependency is gone.
A bioequivalence sample-size workhorse whose news is which regulator it now covers
PowerTOST computes power and sample size for bioequivalence and its changelog reads as a record of regulatory divergence more than statistical development. Version 1.5-3 added the Gulf Co-operation Council as a regulator setting; 1.5-4 and 1.5-6 stripped 'FDA' out of the narrow-therapeutic-index function names once China's CDE began requiring the same evaluation. The most recent release, 1.5-7, is a single fix to how nvec() splits a total sample size across sequences.
humind turns household survey data into Multi-Sector Needs Index severity scores across WASH, Protection, SNFI, Food Security, Education and Health. Its version line tracks the annual MSNI framework revision — 2024.x, 2025.x, 2026.x — with narrow correctness patches between rollouts. v2026.2.0 is the current rollout and the most structural one in the visible history: water-quantity scoring moved out into a new mandatory prerequisite, food-security severity now comes from a different matrix, and the impactR4PHU runtime dependency is gone.
Two things move together. The framework content is revised yearly — indicators added, weights corrected, instruments swapped — and the package keeps absorbing pipeline it used to delegate, most visibly by vendoring add_fcs(), add_hhs(), add_rcsi(), add_lcsi() and add_fcm_phase() locally rather than importing them. Each rollout is explicitly breaking and the release notes have grown per-function 'Action:' instructions, which reads as maintainers who expect every downstream dashboard to need rewiring on the same annual clock.
The 2025 line settled into narrow patches immediately after its rollout — 1.2, 1.3 and 1.4 fixed a separator argument, a schema rename and a shelter misclassification rather than adding indicators. Expect the 2026 line to do the same: correctness fixes against the new WASH, FCLCM and shelter-damage logic before any further framework change.
PowerTOST computes power and sample size for bioequivalence and its changelog reads as a record of regulatory divergence more than statistical development. Version 1.5-3 added the Gulf Co-operation Council as a regulator setting; 1.5-4 and 1.5-6 stripped 'FDA' out of the narrow-therapeutic-index function names once China's CDE began requiring the same evaluation. The most recent release, 1.5-7, is a single fix to how nvec() splits a total sample size across sequences.
The package is in long maintenance with a widening regulatory surface: the statistical methods are settled, and releases arrive when an agency publishes a framework that can be expressed as a settings variant of an existing method. Function naming has been deliberately decoupled from any single agency, with the deprecated FDA-suffixed aliases carried for years before removal. Cadence has slowed to roughly one release every eighteen months.
The next release is most likely another regulator setting or a small fix; on the deprecation notice already given, the power.NTIDFDA()-style aliases are the obvious removal candidate.
Other Infra & APIs products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either humind or PowerTOST.
artoo makes any-to-any clinical dataset conversion lossless by construction.
tabular went from clinical tables to complete TFL output in under two months.
usmapdata ships its 2025 shapefiles on the year-indexed model it adopted in 0.4.0.
glcdp reaches 1.0.0 with a stable schema contract behind its data explorer.
prova adds expected-utility calculation on top of its Bayesian inference core.
checkhelper grew from a check wrapper into a CRAN pre-submission auditor.
See all humind alternatives → · See all PowerTOST alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. humind is currently shipping more aggressively (velocity 3.8 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. humind is currently shipping more aggressively (velocity 3.8 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Infra & APIs products to evaluate alongside.
Top humind alternatives in Infra & APIs are ranked by recent ship velocity. Browse the "humind alternatives" section above for the current picks, or visit /alternatives/humind for the full list with editorial commentary on each.
Top PowerTOST alternatives in Infra & APIs are ranked by recent ship velocity. Browse the "PowerTOST alternatives" section above for the current picks, or visit /alternatives/powertost for the full list with editorial commentary on each.